Door de feestdagen en inventaris, kan je bestelling vertraging oplopen en dat tot 10 januari. Bestellingen van Engelstalige titels kunnen in de meeste gevallen pas na 10 januari uitgeleverd worden.
met een
Acco-aandeel
levenslang korting op Acco-uitgaven, kantoormateriaal en een selectie titels.
Inhoud
This Clinical Handbook for the Management of Mood Disorders will equip clinicians with the knowledge to refine their diagnostic skills and implement treatment plans for mood disorders based on the most up-to-date evidence on interventions that work. Covering the widest range of treatments and techniques, it provides clear guidance for the management of all types and subtypes of both minor and major depression. Chapters cover the latest and most innovative treatments, including use of ketamine, deep brain stimulation and transcranial magnetic stimulation, effective integration of pharmacological and psychotherapeutic approaches, as well as providing a thought-provoking look at the future research agenda and the potential for reliable biomarkers. This is the most comprehensive review of depression available today. Written and edited by leading experts mostly from Columbia University, this is an essential resource for anyone involved in the care and treatment of patients with mood disorders. Table of Contents Preface; Part I. Introduction: 1. Models of depression Steven P. Roose, Patrick J. McGrath and J. John Mann; 2. Diagnosis of mood disorders Michael B. First and Jean Endicott; 3. Dysthymia and chronic depression David J. Hellerstein and Jordan W. Eipper; Part II. Medical Management: 4. Management of adult major depressive disorder J. John Mann, Steven P. Roose and Patrick J. McGrath; 5. Atypical depression Jonathan W. Stewart; 6. Psychotic depression Barnett S. Meyers and Jimmy N. Avari; 7. Pharmacologic and somatic treatments for bipolar depression Lucas Giner, S. Aiden Kelly and Maria A. Oquendo; 8. Medication treatment of mania: acute and preventive David A. Kahn; 9. Treatment of mood disorders in later life Steven P. Roose and Devangere P. Devanand; 10. Chronic depression James H. Kocsis and Benjamin D. Brody; 11. Pediatric depression David A. Brent; 12. Therapeutics of pediatric bipolar disorder Robert A. Kowatch, Melissa P. DelBello and Barbara L. Gracious; 13. Depression in the context of physical illness Peter A. Shapiro, Philip R. Muskin and Emily Gastelum; 14. Mood disorders in the context of borderline personality disorder Eric A. Fertuck, Megan S. Chesin and Barbara H. Stanley; 15. Depression in the context of pregnancy Margaret G. Spinelli and Carolyn Broudy; 16. Depression and the menstrual cycle Benicio N. Frey, Luciano Minuzzi, Roberto Sassi and Meir Steiner; 17. Depression in the context of alcoholism and other substance use disorders Edward V. Nunes, Jr and Frances R. Levin; 18. Complementary and alternative treatments for mood disorders Drew Ramsey, M. Elizabeth Sublette and Philip R. Muskin; Part III. Psychotherapies for Mood Disorders: 19. Cognitive behavior therapy Michael E. Thase; 20. Interpersonal therapy Myrna M. Weissman, Annie E. Rabinovitch and Helena Verdeli; 21. Dialectical behavioral therapy for mood disorders Barbara H. Stanley and Megan S. Chesin; 22. The psychodynamic treatment of mood disorders Deborah L. Cabaniss, Diana E. Moga and Aerin M. Hyun; 23. Combining medication and psychotherapy in the treatment of depression Bret R. Rutherford and Steven P. Roose; Part IV. Specific Modalities of Treatment: 24. Electroconvulsive therapy Joshua Berman and Joan Prudic; 25. Transcranial magnetic stimulation and deep brain stimulation Sarah H. Lisanby and Moacyr A. Rosa; 26. Chronotherapeutics: light therapy, wake therapy, and melatonin Michael Terman and Jiuan Su Terman; 27. Ketamine in treatment-resistant depression Kyle Lapidus and Sanjay J. Mathew; Part V. The Promise of Biomarkers and Response Prediction: 28. Brain imaging Ramin V. Parsey and Martin J. Lan; 29. Pharmacogenetics and mood disorders Gonzalo Laje and Francis J. McMahon; 30. Electrophysiological predictors of clinical response to antidepressants Gerard E. Bruder, Craig E. Tenke and Jürgen Kayser; Part VI. Future Directions: 31. Future directions Patrick J. McGrath, Steven P. Roose and J. John Mann; Index. J. John Mann is Division Director, Molecular Imaging and Neuropathology, New York State Psychiatric Institute, and the Paul Janssen Professor of Translational Neuroscience in Psychiatry and Radiology, College of Physicians and Surgeons of Columbia University, New York, NY, USA. Patrick J. McGrath is Co-Director of the Depression Evaluation Service, New York State Psychiatric Institute, and Professor of Clinical Psychiatry, College of Physicians and Surgeons of Columbia University, New York, NY, USA. Steven P. Roose is Director of the Neuropsychiatry Research Clinic, New York State Psychiatric Research Institute, and Professor of Clinical Psychiatry, College of Physicians and Surgeons of Columbia University, New York, NY, USA.
Je e-mailadres werd genoteerd. We informeren je wanneer dit artikel opnieuw beschikbaar is.
In welke staat is je boek?
Een belangrijke factor van een tweedehands boek is de staat van het boek. De koper mag niet voor verrassingen komen te staan. Vermeld steeds duidelijke beschadigingen of gebreken. We gebruiken een systeem met 3 sterren:
Het boek is acceptabel: je hebt het noest gebruikt om te leren en notities en markeringen aangebracht – maar alles is nog leesbaar. De kaft en pagina’s zijn in goede staat.
Het boek ziet er nog goed uit: er staan enkele notities in en je hebt er in gemarkeerd. Er zijn nauwelijks gebruikssporen aan de kaft en pagina’s.
Het boek is (zo goed als) nieuw: je hebt er niet in geschreven en niet gemarkeerd. Er zijn geen gebruikssporen aan de kaft en pagina’s.
Voor deze download heb je een code nodig.
Je code is niet correct. Probeer het opnieuw.
Meld je aan
Nog niet geregistreerd?
Registreer je om een Acco-aandeel aan te kopen of te koppelen en geniet meteen van korting. Inloggen/registreren is ook nodig om bepaalde bestanden te downloaden.